High Tech Pharm Co., Ltd. (KOSDAQ:106190)

High Tech Pharm Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	140,358	148,864	99,208	77,268	97,116	130,788
Market Cap Growth	50.05%	50.05%	28.39%	-20.44%	-25.75%	63.27%
Enterprise Value	140,601	153,628	111,271	89,346	110,402	138,335
Last Close Price	13200.00	14000.00	9263.36	7164.94	8948.68	12007.34
PE Ratio	10.24	10.86	12.28	13.16	-	-
PS Ratio	1.81	1.92	1.29	0.75	1.33	1.76
PB Ratio	1.17	1.24	0.93	0.77	1.03	1.38
P/TBV Ratio	1.17	1.24	0.93	0.77	1.03	1.38
P/FCF Ratio	11.18	11.85	-	-	16.00	-
P/OCF Ratio	9.55	10.13	34.11	-	14.02	-
EV/Sales Ratio	1.81	1.98	1.45	0.87	1.51	1.86
EV/EBITDA Ratio	6.78	7.41	7.38	8.53	21.49	64.99
EV/EBIT Ratio	9.04	9.88	11.03	18.13	-	-
EV/FCF Ratio	11.20	12.23	-	-	18.19	-
Debt / Equity Ratio	0.07	0.07	0.15	0.16	0.17	0.11
Debt / EBITDA Ratio	0.39	0.39	1.09	1.57	3.11	4.92
Debt / FCF Ratio	0.64	0.64	-	-	2.63	-
Asset Turnover	0.56	0.56	0.57	0.81	0.58	0.57
Inventory Turnover	1.92	1.92	3.18	5.88	3.86	5.13
Quick Ratio	1.48	1.48	1.31	1.15	0.97	0.77
Current Ratio	3.39	3.39	2.48	1.64	1.78	1.50
Return on Equity (ROE)	12.09%	12.09%	7.81%	6.06%	-1.30%	-3.25%
Return on Assets (ROA)	7.07%	7.07%	4.72%	2.41%	-0.21%	-1.60%
Return on Capital (ROIC)	7.74%	7.74%	5.26%	2.72%	-0.24%	-1.93%
Return on Capital Employed (ROCE)	12.80%	12.80%	9.00%	4.90%	-	-
Earnings Yield	9.77%	9.21%	8.14%	7.60%	-1.26%	-2.41%
FCF Yield	8.95%	8.44%	-2.20%	-5.64%	6.25%	-6.60%
Payout Ratio	5.17%	5.17%	6.14%	6.04%	-	-
Buyback Yield / Dilution	-0.09%	-0.09%	0.06%	-0.08%	0.00%	0.08%

Updated Mar 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.